DEVICE FOR THE SUBCUTANEOUS ADMINISTRATION OF A MEDICATION

The device addresses issues of incorrect orientation and patient access by using a modular design with a hidden inspection window, ensuring secure and stable subcutaneous medication administration.

FR3140765B3Active Publication Date: 2024-11-15NUOVA OMPI SRL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
FR2023011049
Authority / Receiving Office
FR · FR
Patent Type
Utility models
Current Assignee / Owner
Priority Date
2022-10-14
Filing Date
2023-10-13
Publication Date
2024-11-15
Estimated Expiration
2033-10-13

AI Technical Summary

Technical Problem

Existing subcutaneous medication administration devices with external inspection windows pose challenges such as incorrect device orientation during application, patient access to medication status during administration, and potential device movement, leading to safety risks.

Method used

A subcutaneous administration device designed with two modules - one for the cartridge and one for the control unit - where the inspection window is accessible only before coupling, ensuring it is not visible during or after administration, using a configuration that keeps the window covered when the modules are coupled.

Benefits of technology

Prevents unauthorized access to the inspection window during and after administration, ensuring correct device orientation and reducing safety hazards by maintaining the device's stability on the patient's body.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000023_0000
    Figure 00000023_0000
  • Figure 00000023_0001
    Figure 00000023_0001
  • Figure 00000024_0000
    Figure 00000024_0000
Patent Text Reader

Abstract

The present invention relates to a device for the subcutaneous administration of a drug, comprising a delivery module (10) configured to house a cartridge containing a drug to be administered to a patient via a needle, and a control module reversibly coupled to the delivery module (10) and configured to house at least one control unit and a battery to power said control unit. The delivery module (10) includes a first interface surface (115) facing the control module (20). The control module includes a second interface surface facing the first interface surface (115). The first interface surface (115) includes an inspection window (125) covered by the second interface surface and configured to allow visual inspection of the cartridge when the control module is decoupled from the delivery module (10). [Fig. 2]
Need to check novelty before this filing date? Find Prior Art

Description

Title of the invention: DEVICE FOR THE SUBCUTANEOUS ADMINISTRATION OF A MEDICINE Technical field of the invention

[0001] The present invention relates to a device for the subcutaneous administration of a medicament.

[0002] In particular, the device of the present invention falls within the category of "infusion pumps" as defined by the FDA (US Food and Drug Administration) and relates, more particularly, to an ambulatory device, i.e. a device configured to be applied to the patient's body to enable the subcutaneous administration of a predetermined dose of medication.

[0003] The application of the device to the patient's body is carried out by a user, for example a doctor or a nurse or the patient. Technical background

[0004] Examples of ambulatory subcutaneous administration devices are described in EP 3439715B1 and WO 2020 / 128821A1.

[0005] In all of the aforementioned devices, the drug is initially contained in a cartridge which is housed within the device and is transferred to the patient's body via a fluid path.

[0006] In the present description, the term "fluidic path" is used to indicate any element or assembly which is configured to be connected, at a first end thereof, to the cartridge housed inside a device for the subcutaneous administration of a medicament and comprising, at an end thereof opposite the aforementioned first end, a needle intended to be inserted into the patient's body, to allow the passage of the medicament from the cartridge to the patient's body via said needle.

[0007] Some ambulatory subcutaneous administration devices have an inspection window to allow inspection of the medication inside the cartridge before starting to administer the medication. In fact, it is recommended that the medication be administered to the patient only after visually verifying that the medication is intact.

[0008] Examples of ambulatory type subcutaneous administration devices with an inspection window are described in WO 2006 / 024650A2, WO 2003 / 099358A2, WO 2006 / 077262A1.

[0009] The Applicant observed that, in all of the above-mentioned examples, the window inspection device is positioned on an external surface of the delivery device. In particular, in the devices described in WO 2006 / 024650A2 and WO 2003 / 099358A2, the inspection window is arranged on the outer surface facing away from the patient's body after the delivery device has been applied to the patient's body, while in WO 2006 / 077262A1, the inspection window is arranged on the outer surface facing toward the patient's body after the delivery device has been applied to the patient's body.

[0010] The Applicant has found that, in devices in which the inspection window is arranged on the external surface intended to face away from the patient's body, as for example in the devices described in WO 2006 / 024650A2 and WO 2003 / 099358A2, the inspection window is always accessible to the user's view (in the following this condition will also be briefly indicated by the term "visible").

[0011] According to the Applicant, this brings with it a number of drawbacks, some of which are discussed below.

[0012] A first drawback is correlated with the fact that, typically, a control interface of the administration device, such as for example one or more buttons or one or more LEDs, is also provided on said external surface. In this case, during the application of the administration device to the patient's body, the user (in particular a non-expert user) could not immediately identify the correct orientation to give to the administration device in order to position it correctly on the patient's body. Indeed, the user may wonder, for example, whether to orient the administration device in order to facilitate visual access to the inspection window or to the control interface, thus risking opting for a position other than the correct position. In this case, the user may not be able to see possible error messages that are communicated via the control interface.

[0013] Another disadvantage is correlated with the fact that, since the inspection window is visible, the patient might be able to inspect the medication that is within the cartridge even at the end of the administration cycle. Therefore, if, for example, the administration therapy has not provided for the administration of the entire dose of medication that is within the cartridge, the patient, seeing that not all the medication that is within the cartridge has been administered, might become concerned, without there actually being anything abnormal.

[0014] The Applicant has also found that, in those devices in which the inspection window is arranged on the external surface intended to face towards the patient's body, as for example in the device described in WO 2006 / 077262A1, during the administration of the drug, the patient could decide to move the administration device to have visual access to the inspection window and check, perhaps just out of curiosity, the amount of medication that has been administered and / or the amount that is still present in the cartridge. It goes without saying that it would be rather advisable to avoid any movement of the administration device once it has been applied to the patient's body, so as not to risk causing various problems, such as for example the accidental detachment of the device from the patient's body or the breakage of the needle inserted into the patient's body.

[0015] The Applicant has therefore realized the need to provide a subcutaneous administration device in which the inspection window is arranged in a position such that it is visible only before the start of the administration therapy and not also during the administration or at the end of the administration, when the device is still applied to the patient's body.

[0016] The Applicant has realized that in order to satisfy this need, it is appropriate for the administration device to consist of two separate modules, one configured to house the cartridge and the other configured to house control components of the device, in particular a control unit and the battery for power supply of said control unit, said modules being further configured to be mutually coupled at respective interface surfaces which, after coupling the two modules, have respective surface portions which are not visible. The Applicant has therefore thought of arranging the inspection window on the interface surface of the module in which the cartridge is housed and at a portion of the surface which is covered by the other interface surface when the two modules are mutually coupled.In this way, the inspection window is visible only before the two modules are mutually coupled, while it is not accessible, not even visually, during the administration of the drug and at the end of the administration when the two modules are still coupled to each other. Summary of the invention

[0017] The present invention therefore relates to a device for the subcutaneous administration of a medicament, comprising:

[0018] - an administration module configured to house a cartridge containing a me medicine to be administered to a patient via a needle;

[0019] - a control module reversibly coupled to the administration module and configured to house at least one control unit and a battery for supplying power to said control unit;

[0020] wherein said administration module comprises a first interface surface facing the control module and said control module comprises a second interface surface facing the first interface surface;

[0021] wherein said first interface surface comprises an inspection window covered by the second interface surface and configured to allow visual inspection of the cartridge when said control module is decoupled from the administration module.

[0022] Such a device prevents the user from any possibility of accessing the inspection window once the administration device is coupled to the patient's body. The inspection window is in fact only accessible before the administration module and the control module are coupled together. To gain access to the inspection window after coupling the two modules, it is necessary to decouple them, an operation which is obviously carried out only at the end of the administration of the therapy.

[0023] The above-mentioned device may comprise one or more of the following features, taken individually or possibly combined with each other.

[0024] Preferably, the administration module is disposable.

[0025] Preferably, the control module is reusable.

[0026] Preferably, the administration module comprises an application surface configured not to come into contact with the patient's body. The administration module therefore comprises two opposite external surfaces: one of these external surfaces defines the interface surface of the administration module and is intended to face away from the portion of the patient's body on which the administration device is to be applied and be covered by the interface surface of the control module when the latter is coupled to the administration module, while the other of the aforementioned external surfaces defines the application surface of the administration module and is intended to face the portion of the patient's body on which the administration device is to be applied.

[0027] Preferably, the administration module is configured to house said cartridge between the application surface and the inspection window and, consequently, between the application surface and the interface surface of the administration module.

[0028] Preferably, the inspection window is parallel to the application surface. This expedient allows easy inspection of the medicament contained in the cartridge when the two modules are decoupled.

[0029] In a preferred embodiment of the device of the present invention, the application surface comprises a light-permeable portion configured to allow external light to reach the cartridge when the application surface is not in contact with the patient's body.

[0030] Preferably, the light-permeable portion and the inspection window overlap each other. In this way, light entering the delivery module through the light-permeable portion of the application surface can reach the inspection window. The presence of the cartridge between the application surface and the inspection window does not hinder the aforementioned light from reaching the inspection window since the cartridges are typically made of transparent material (and therefore of a light-permeable material) to allow the medicament contained therein to be seen.

[0031] Preferably, the light-permeable portion is larger than the inspection window. This expedient allows the inspection window to be reached by a relatively large amount of light.

[0032] Preferably, the application surface comprises an opening configured to allow insertion of the cartridge into the delivery module during assembly of the delivery module.

[0033] Preferably, the light-permeable portion comprises a transparent element fixed at said opening to close said opening. The aforementioned transparent element therefore serves as a closing door for the cartridge housing seat. This door, which is transparent, allows light to enter the administration module to reach the cartridge and the inspection window.

[0034] Preferably, said transparent element is fixed at said opening by laser welding. This type of fixing is possible precisely because the closing door of the cartridge housing seat is transparent.

[0035] Preferably, the application surface comprises an adhesive layer configured to attach the delivery module to the patient's skin.

[0036] Preferably, a portion of said adhesive layer is placed on said transparent element.

[0037] Preferably, said adhesive layer is configured to allow external light to reach the cartridge when the application surface is not in contact with the patient's body. Thus, the aforementioned adhesive layer does not hinder the entry of light into the administration module through the light-permeable portion of the application surface.

[0038] Preferably, said adhesive layer is not transparent, so as to prevent the user from being able to see the cartridge through the transparent element. Brief description of the Figures

[0039] The features of the present invention will become apparent from the following detailed description of certain exemplary embodiments thereof, provided by way of non-limiting examples. Such description will be made with reference to the drawings annexed, in which:

[0040] [Fig-1] represents a perspective view of a device for the subcutaneous administration of a drug according to the present invention;

[0041] [Fig.2] represents a perspective view of a part of the device of [Fig.l];

[0042] [Fig.3] represents a bottom view of the part of [Fig.2];

[0043] [Fig.4] represents a sectional view of the part of [Fig.2];

[0044] [Fig.5] represents a perspective view of another part of the device of [Fig.l]

[0045] [Fig.6] represents a bottom view of the part of [Fig.5];

[0046] [Fig.7] represents a profile view of the part of [Fig.5];

[0047] [Fig.8] represents an enlargement of certain components of the device of the [Fig.l] in a first operational configuration, with certain parts hidden in order to highlight other parts;

[0048] [Fig.9] represents an enlargement of certain components of the device of the [Fig.l] in a second operational configuration, with some parts hidden in order to represent other parts;

[0049] [Fig. 10] shows an enlargement of certain components of the device of [Fig.l] in a third operational configuration, with certain parts hidden in order to highlight other parts. Detailed description of the invention

[0050] A device for the subcutaneous administration of a medicament, object of the present invention, is shown schematically in [Fig.l] and is indicated by the reference numeral 1.

[0051] The device 1 comprises an administration module 10, shown in Figures 2 to 4, and a control module 20, shown in Figures 5 to 7.

[0052] The device 1 is obtained by the mutual coupling of the administration module 10 and the control module 20. As will become clear in the remainder of this description, this coupling is reversible, that is to say that the two modules 10 and 20, after having been coupled, can be decoupled.

[0053] The administration module 10 comprises an internal housing 101 (shown in [Fig. 4]) configured to house a cartridge (not shown). The cartridge comprises a cylindrical container made of a plastic or glass material containing a medicament to be administered to a patient and a pierceable septum which closes the container and ensures its sterility until the device 1 is used.

[0054] Before the device 1 is used, a fluid path (not shown) configured to allow the passage of the medication from the cartridge to the patient's body is associated with the administration module 10. This fluid path comprises a needle configured to pierce the septum (hereinafter referred to as a “septum needle”), a skin needle configured to be inserted into the patient’s body and a flexible tube that places the aforementioned needles in fluid communication.

[0055] The delivery module 10 further includes a fluid path opening system (not shown) that is configured to move the septum needle and / or the cartridge such that the septum needle pierces the septum and enters into fluid communication with the interior of the cartridge such that the medicament can be removed therefrom.

[0056] The delivery module 10 also includes a skin needle insertion and retraction mechanism (not shown). This mechanism is configured to move the skin needle before the start of therapy by inserting it into the patient's body and at the end of therapy by retracting it from the patient's body.

[0057] The administration module 10 further comprises a kinematic chain (not shown) configured to perform drug administration following the opening of the fluid path and the insertion of the cutaneous needle into the patient's body.

[0058] The administration module 10 is preferably disposable. In other words, the administration module 10 is configured to be applied to the patient's body only once and for a certain duration and to administer, completely or in part, the contents of the cartridge in one or more consecutive injections, even if temporally spaced from each other. The administration module 10 does not provide the possibility of replenishing or replacing the cartridge and is configured to be discarded after removal from the patient's body.

[0059] The administration module 10 comprises an application surface 102 configured to contact the patient's body. The application surface 102 is substantially flat.

[0060] The application surface 102 defines a reference plane. With respect to the application surface 102, the following directions are defined: a first direction DI ([Fig.3]) parallel to the application surface 102 and to a coupling direction A1 of the two modules 10 and 20, a second direction D2 ([Fig.4]) perpendicular to the application surface 102 and a third direction D3 ([Fig.3]) parallel to the application surface 102 and perpendicular to the first direction DI and to the second direction D2. When used in reference to the control module 20 or portions thereof, the first direction DI (Figures 6, 8-10), the second direction D2 ([Fig.7]) and the third direction D3 (Figures 6, 8-10) are to be understood as referring to a configuration of the control module 20 in which the control module 20 is coupled to the administration module 10.

[0061] The application surface 102 comprises a base wall 103 having a substantially rectangular shape, with rounded corners. The base wall 103 has two short sides oriented in the first direction DI and two long sides oriented in the third direction D3.

[0062] The base wall 103 is made of a rigid material, preferably a plastic material. The base wall 103 partially delimits the housing compartment 101 of the administration module 10.

[0063] As shown in [Fig.4], the base wall 103 includes an opening 104 configured to allow the cartridge to be positioned in the housing compartment 101 during assembly of the administration module 10.

[0064] The base wall 103 further comprises a transparent element 105, made for example of a transparent plastic material, fixed to the opening 104 in order to close it. The transparent element 105 is applied during the assembly phase after having introduced the cartridge into the housing compartment 101 through the opening 104 and is fixed to the opening 104 by laser welding.

[0065] The application surface 102 further comprises an adhesive layer 106 configured to attach the delivery module 10 to the patient's body. The adhesive layer 106 has an adhesive side attached to the base wall 103 and an opposing adhesive side configured to be attached to the patient's skin.

[0066] The adhesive layer 106 is configured to be traversed by light. The adhesive layer 106 covers the transparent element 105 and together with the latter forms a light-permeable portion 107 in the application surface 102. The light-permeable portion 107 is configured to allow external light to reach the cartridge in the housing compartment 101 when the application surface is not in contact with the patient's body.

[0067] The adhesive layer 106 is not transparent and is configured to prevent the cartridge in the housing compartment 101 from being seen through the light-permeable portion 107.

[0068] With reference to Figures 1 and 2, the administration module 10 comprises two first opposite perimeter gripping surfaces 110. The first perimeter gripping surfaces 110 extend along the first direction DI and along the second direction D2.

[0069] The first perimeter gripping surfaces 110 are adjacent to the application surface 102 and partially delimit the housing compartment 101 on opposite sides.

[0070] The first perimeter gripping surfaces 110 are placed at opposite short sides of the base wall 103 and form with the base wall 103 an angle substantially equal to 90°.

[0071] The first perimeter gripping surfaces 110 extend along the first direction DI on the same long side of the base wall 103 towards the opposite long side passing over the respective short side.

[0072] The first perimeter gripping surfaces 110 extend in the first direction DI over approximately half the extent of the short sides of the base wall 103.

[0073] The first perimeter gripping surfaces 110 extend from the base wall 103 along the second direction D2 away from the base wall 103.

[0074] The first perimeter gripping surfaces 110 have dimensions that are substantially equal to each other along the first direction DI and the second direction D2. In particular, the two first perimeter gripping surfaces 110 are mirror-image relative to a first central plane of the administration module 10 extending along the first direction DI and the second direction D2.

[0075] Still with reference to Figures 1 and 2, the administration module 10 comprises a third perimeter surface 111 extending along the second direction D2 and the third direction D3.

[0076] The third perimeter surface 111 is adjacent to the application surface 102 and partially delimits the housing compartment 101.

[0077] The third perimeter surface 111 is placed at one of the long sides of the base wall 103 and forms with the base wall 103 an angle substantially equal to 90°.

[0078] The third perimeter surface 111 extends from the base wall 103 along the second direction D2 away from the base wall 103.

[0079] The third perimeter surface 111 extends along the third direction D3, from one first perimeter gripping surface 110 to the other first perimeter gripping surface 110 passing over the respective long side of the base wall 103.

[0080] The third perimeter surface 111 has a dimension substantially equal to the dimension of the first perimeter gripping surfaces 110 in the second direction D2.

[0081] Each first perimeter gripping surface 110 is joined to the third perimeter surface 111 by a rounded joining portion.

[0082] As shown in Figures 2 and 4, the administration module 10 includes a first interface surface 115 configured to be arranged to face the control module 20 when the administration module 10 is coupled to the control module 20. The first interface surface 115 faces away from relative to the application surface 102.

[0083] The first interface surface 115 comprises a first interface portion 116. The first interface portion 116 is defined in the portion of the administration module 10 which is more distal from the application surface 102 along the second direction D2.

[0084] The first interface portion 116 extends from one of the first perimeter gripping surfaces 110 to the other of the first perimeter gripping surfaces 110. The first interface portion 116 extends from the third perimeter surface 111 along the first direction DI. The first interface portion 116 partially delimits the housing compartment 101 on the opposite side relative to the base wall 102.

[0085] The first interface portion 116 has a concave profile defined by two opposite surfaces 117 parallel to the first two perimeter gripping surfaces 110 and a connecting surface 118 parallel to the third perimeter surface 111.

[0086] Each of the two opposite surfaces 117 of the concave profile of the first interface portion 116 is closer to the respective first perimeter gripping surface 110 than to the first central plane of the administration module 10.

[0087] The connecting surface 118 of the concave profile of the first interface portion 116 is closer to the third perimeter surface 111 than to a centerline plane of the administration module 10 extended along the second direction D2 and the third direction D3.

[0088] As shown in [Fig.2], the first interface surface 115 further comprises a second interface portion 120 substantially parallel to the application surface 102. The second interface portion 120 is positioned at a smaller distance from the application surface 102 than the first interface portion 116.

[0089] The second interface portion 120 extends along the third direction D3, from one of the short sides to the opposite short side of the rectangular profile of the base wall 103 and, along the first direction D1, from the long side opposite the third perimeter wall 111 towards the third perimeter wall 111.

[0090] The second interface portion 120 does not extend between the first perimeter gripping surfaces 110.

[0091] Still with reference to [Fig.2], the first interface surface 115 further comprises a third interface portion 121 extending from the second interface portion 120 to the first interface portion 116 and from one of the first perimeter gripping surfaces 110 to the other of the first perimeter gripping surfaces 110. The third interface portion 121 delimits the housing compartment 101 on the opposite side relative to the third perimeter portion 111.

[0092] The third interface portion 121 comprises respective ends 122 placed at the first perimeter gripping surfaces 110 and a projecting portion 123 placed between the ends 122 and projecting on the opposite side relative to the third perimeter surface 111.

[0093] The first interface surface 115 further comprises a first circular portion 124. The first circular portion 124 is configured to allow a drive rotor (not shown) provided in the control module 10 to rotationally actuate by magnetic coupling a magnetic rotor (not shown) provided in the delivery module 10 at the first circular portion 124 when the control module 20 is coupled to the delivery module 10.

[0094] The first circular portion 124 is placed between the first interface portion 116 and the third interface portion 121. The first circular portion 124 partially delimits the housing compartment 101 on the opposite side relative to the application surface 102 and defines a recess relative to the first interface portion 116.

[0095] The first interface surface 115 further comprises an inspection window 125 (Figures 2 and 4) configured to allow visual inspection of the cartridge when the control module 20 is decoupled from the administration module 10.

[0096] The inspection window 125 is placed at the first interface portion 116, overlapping the housing compartment 101. The inspection window 125 is parallel to the application surface 102.

[0097] The inspection window 125 is placed on the opposite side of the housing compartment 101 with respect to the light-permeable portion 107. In particular, the inspection window 125 and the light-permeable portion 107 overlap each other. More particularly, the inspection window 125 and the light-permeable portion 107 are arranged such that the cartridge is positioned therebetween.

[0098] The light permeable portion 107 is larger than the inspection window 125.

[0099] The inspection window 125 is configured to be covered by the control module 20, when the control module 20 is coupled to the administration module 10, so as to prevent visual inspection of the cartridge.

[0100] The control module 20 is preferably of a different color than and / or of a different material than the administration module 10, so as to help the user distinguish the two modules during coupling.

[0101] The control module 20 in turn comprises a housing (not shown) inside which a control unit is housed, which is usually made up of a printed circuit and configured to control the administration of the drug. by the administration module 10, and a power supply battery configured to supply power to the control unit.

[0102] As shown in Figures 1 and 5, the control module 20 includes an upper surface 202 extending substantially parallel to the application surface 102 when the control module 20 is coupled to the administration module 10.

[0103] The upper surface 202 has a substantially rectangular shape, with rounded corners, mirroring the shape of the base wall 103. Therefore, similarly to the latter, the upper surface 202 has two short sides oriented in the first direction DI and two long sides oriented in the third direction D3.

[0104] The control module 20 comprises two second opposite perimeter gripping surfaces 210. The second opposite perimeter gripping surfaces 210 extend along the first direction DI and along the second direction D2.

[0105] The second perimeter gripping surfaces 210 are adjacent to the upper surface 202 and partially delimit the aforementioned housing on opposite sides.

[0106] The second perimeter gripping surfaces 210 are placed at opposite short sides of the upper surface 202 and form with the upper surface 202 an angle substantially equal to 90°.

[0107] The second perimeter gripping surfaces 210 extend along the first direction DI on the same long side of the upper surface 202 towards the opposite long side passing over the respective short side.

[0108] The second perimeter gripping surfaces 210 extend along the first direction DI over approximately half the extent of the short sides of the upper surface 202.

[0109] The second perimeter gripping surfaces 210 extend from the upper surface 202 along the second direction D2 away from the upper surface 202, i.e. towards the application surface 102 when the control module 20 is coupled to the administration module 10.

[0110] The second perimeter gripping surfaces 210 have dimensions substantially equal to each other along the first direction DI and the second direction D2. In particular, the two second perimeter gripping surfaces 210 are mirror-image relative to a second central plane of the control module 20 extending along the first direction DI and the second direction D2 and coinciding with the first central plane of the administration module 10 when the control module 20 is coupled to the administration module 10.

[0111] Furthermore, the first two perimeter gripping surfaces 110 and the two second perimeter gripping surfaces 210 have substantially equal dimensions along the first direction D1.

[0112] When the control module 20 is coupled to the dispensing module 10, each first perimeter gripping surface 110 is adjacent to, and aligned with, or flush with, a respective second perimeter gripping surface 210 to define a substantially continuous lateral surface of the device 1.

[0113] As shown in Figures 1, 5 to 7, the control module 20 comprises a fourth perimeter surface 211 extending along the second direction D2 and the third direction D3.

[0114] The fourth perimeter surface 211 is adjacent to the upper surface 202 and partially delimits the aforementioned housing.

[0115] The fourth perimeter surface 211 is placed at one of the long sides of the upper surface 202 and forms with the upper surface 202 an angle substantially equal to 90°.

[0116] The fourth perimeter surface 211 extends from the upper surface 202 along the second direction D2 away from the upper surface 202, i.e. towards the application surface 102 when the control module 20 is coupled to the administration module 10.

[0117] The fourth perimeter surface 211 extends along the third direction D3, from one second perimeter gripping surface 210 to the other second perimeter gripping surface 210 passing over the respective long side of the upper surface 202.

[0118] The fourth perimeter surface 211 has a dimension substantially equal to the dimension of the second perimeter gripping surfaces 210 in the second direction D2.

[0119] Each second perimeter gripping surface 210 is joined to the fourth perimeter surface 211 by a rounded joining portion 212.

[0120] When the control module 20 is coupled to the administration module 10, the fourth perimeter surface 211 is arranged substantially parallel to the third perimeter surface 111, on the side opposite the latter.

[0121] The sum of the dimensions of any one of the first perimeter gripping surfaces 110 and any one of the second perimeter gripping surfaces 210 along the first direction D1 is less than the dimension of the third perimeter surface 111 and the fourth perimeter surface 211 along the third direction D3.

[0122] As shown in Figures 6 and 7, the control module 20 includes a second interface surface 215 configured to be arranged to face the first interface surface 115 of the administration module 10 when the module administration module 10 is coupled to the control module 20.

[0123] The second interface surface 215 is substantially counter-shaped to the first interface surface 115 and faces away from the upper surface 202.

[0124] The second interface surface 215 comprises a first interface portion 216 substantially parallel to the upper surface 202. The first interface portion 216 of the control module 20 is substantially counter-shaped to the second interface portion 120 of the administration module 10 and is configured to be arranged so as to face the latter.

[0125] The first interface portion 216 is defined in the portion of the control module 20 which is more distal from the upper surface 202 along the second direction D2.

[0126] The first interface portion 216 extends from one of the second perimeter gripping surfaces 210 to the other second perimeter gripping surface 210. The first interface portion 216 is adjacent to the fourth perimeter surface 211 and extends from the third perimeter surface 211 along the first direction DI. The first interface portion 216 partially delimits the aforementioned housing on the opposite side relative to the upper surface 202.

[0127] The second interface surface 215 further comprises a second interface portion 220 placed at a smaller distance from the upper surface 202 than the first interface portion 216. The second interface portion 220 is substantially counter-shaped to the first interface portion 116 of the administration module 10 and is configured to be arranged so as to face the latter.

[0128] The second interface portion 220 extends along the third direction D3, from one of the short sides to the opposite short side of the rectangular profile of the upper surface 202 and, along the first direction D1, from the long side opposite the fourth perimeter wall 211 towards the fourth perimeter wall 211.

[0129] The second interface portion 220 has a convex profile, substantially mirror-image to the concave profile of the first interface portion 116.

[0130] The convex profile of the second interface portion 220 is defined by two opposite surfaces 217 parallel to the first two perimeter gripping surfaces 110 and a connecting surface 218 parallel to the fourth perimeter surface 211.

[0131] Each of the two opposite surfaces 217 of the convex profile of the second interface portion 220 is closer to the respective second perimeter gripping surface 210 than to the second central plane of the control module 20.

[0132] The connecting surface 118 of the concave profile of the first interface portion 116 and the connecting surface 218 of the convex profile of the second interface portion 220 are closer to the third perimeter surface 111 than to a central plane of the device 1 extending along the second direction D2 and the third direction D3 when the control module 20 is coupled to the administration module 10.

[0133] The second interface surface 215 further comprises a third interface portion 221 extending from the second interface portion 220 to the first interface portion 216 and from one of the second perimeter gripping surfaces 210 to the other of the second perimeter gripping surfaces 210. The third interface portion 221 delimits the aforementioned housing on the opposite side relative to the fourth perimeter wall 211.

[0134] The third interface portion 221 of the control module 20 is substantially counter-shaped to the third interface portion 121 of the administration module 10 and is configured to be arranged so as to face the latter.

[0135] The third interface portion 221 comprises respective ends 222 placed at the second perimeter gripping surfaces 210 and a hollowed-out portion 223 placed between the ends 222 and which is hollowed out towards the fourth perimeter surface 211.

[0136] The second interface surface 215 further comprises a second circular portion 224. The second circular portion 224 of the control module 20 is substantially counter-shaped to the first circular portion 124 of the administration module 10 and is configured to be arranged so as to face the latter.

[0137] The first circular portion 124 and the second circular portion 224 are configured to allow precise alignment between the drive rotor provided in the control module at the second circular portion 224 and the magnetic rotor provided in the delivery module 10 at the first circular portion 224 when the control module 20 is coupled to the delivery module 10.

[0138] The second circular portion 224 is placed between the second interface portion 220 and the third interface portion 221 and defines a projection relative to the second interface portion 220.

[0139] The second interface surface 215, in particular the first interface portion 220 of the second interface surface 215, is configured to cover the inspection window 125 when the control module 20 is coupled to the administration module 10 so as to prevent visual inspection of the cartridge.

[0140] One or more seals (not shown) are interposed between at least a portion of the first interface surface 115 and at least a portion of the second interface surface 215 in order to ensure the sealing of the coupling between the administration module 10 and the control module 20.

[0141] As shown in [Fig.2], the administration module 10 comprises opposing coupling recesses 130 extending along the first direction DI. The coupling recesses 130 are placed near the first perimeter gripping surfaces 110. In particular, the coupling recesses 130 are placed at the first interface portion 116. The coupling recesses 130 extend from the opposing surfaces 117 of the concave profile of the first interface portion 116 towards the first perimeter gripping surfaces 110.

[0142] As shown in [Fig.5], the control module 20 comprises opposing coupling projections 230 extending along the first direction DI. The coupling projections 230 are configured to slide in the coupling recesses 130 during coupling of the control module 20 to the administration module 10 so as to guide the sliding thereof along the coupling direction AL. The coupling projections 230 are placed near the second perimeter gripping surfaces 210.

[0143] As shown in Figures 6 and 7, the control module 20 includes a locking projection 300.

[0144] The locking projection 300 extends from the second interface surface 215 of the control module 20 along a development direction perpendicular to the coupling direction A1 and parallel to the second direction D2. More particularly, the locking projection 300 extends from the first interface portion 216 of the second interface surface 215 along the aforementioned development direction. When the control module 20 is coupled to the administration module 10, the locking projection 300 protrudes toward the application surface 102.

[0145] The locking projection 300 comprises a rod 301 extending along the aforementioned development direction from the second interface surface 215 and having an end 302, and a tooth 303 extending from the end 302 parallel to the coupling direction AL

[0146] The locking projection 300 comprises a pushing portion 304 extending along the aforementioned development direction and a hooking portion 305 extending from the pushing portion 304 along a direction parallel to the coupling direction A1, i.e., parallel to the first direction D1. The hooking portion 302 comprises a surface placed on the tooth 303, substantially parallel to the application surface 102, and facing towards the second interface surface 215.

[0147] The locking projection 300 is placed at the second central plane of the control module 20.

[0148] The control module 20 further comprises a closing projection 310 extending along a development direction parallel to the development direction of the locking projection 300. In particular, the closing projection 310 extends along the second direction from the second interface surface 215. More particularly, the closing projection 310 extends from a mutual joining edge of the second interface surface 215 and the fourth perimeter surface 211, flush with the fourth perimeter surface 211.

[0149] The closing projection 310 is placed at the second central plane of the control module 20 and is spaced from the locking projection 300 along the coupling direction A1.

[0150] As shown in Figures 2, 8 to 10, the administration module 10 includes a seat 400 configured to cooperate with the locking projection 300 during coupling between the administration module 10 and the control module 20.

[0151] The seat 400 comprises an inlet 401 configured to receive the locking projection 300. The inlet 401 is placed on the first interface surface 115, in particular on the second interface portion 120 of the first interface surface 115, at one of the long sides of the base wall 103.

[0152] The seat 400 further comprises an internal volume 402 configured to accommodate the locking projection 300 at the end of the coupling between the administration module 10 and the control module 20. The internal volume 402 is contiguous to the inlet 401 along the coupling direction AL

[0153] The seat 400 also comprises a coupling portion 403 overlapping the inlet 401 and the internal volume 402 ([Fig.2]).

[0154] The coupling portion 403 is defined between two opposite guide surfaces 404 extending from the inlet 401 to the internal volume 402 along the coupling direction AL. In particular, the guide surfaces 404 extend along the first direction DI and the second direction D2 and are parallel to each other. The guide surfaces 404 are adjacent to the second interface portion 121 of the first interface surface 115.

[0155] The guide surfaces 404 are configured to guide the locking projection 300 between the inlet 401 and the internal volume 402 during coupling of the control module 20 with the administration module 10.

[0156] The coupling portion 403 further comprises a stop surface 405 extending perpendicular to the coupling direction A1 and facing the internal volume 402. The stop surface 405 extends between the two guide surfaces 404 along the third direction D3 and the second direction D2. The stop surface 405 is adjacent to the second interface portion 121 of the first interface surface 115 and defines a stop for the locking projection 300 along the coupling direction A1.

[0157] The seat 400 further comprises a hooking surface, not shown in the attached Figures, configured to be arranged in abutment against the hooking portion 305 of the locking projection 300 when the locking projection 300 is housed in the internal volume 402, as in the configuration of [Fig. 10]. The attachment surface is substantially parallel to the application surface 102 and faces towards the application surface 102.

[0158] As shown in Figures 8 to 10, the administration module 10 further comprises a slider 410 associated with the seat 400 and slidably movable between a first position and a second position along an operating direction M1 perpendicular to the coupling direction A1 and parallel to the application surface 102. In particular, the operating direction M1 is parallel to the third direction D3.

[0159] The slider 410 comprises a main body 411 slidably mounted in the seat 400.

[0160] The main body 411 includes a service portion 412 shaped to obstruct the inlet 401 when the slider 410 is in the first position and not to obstruct the inlet 401 when the slider 410 is in the second position. When the slider 410 is in the first position, the service portion 412 is arranged at the coupling portion 403. When the slider 410 is in the second position, the service portion 412 is arranged in a position that is adjacent to the coupling portion 403.

[0161] The service portion 412 comprises a thrust surface 413 facing the inlet 401 when the slider 410 is in the first position. The thrust surface 413 is oriented obliquely relative to the coupling direction AL. In particular, the thrust surface 413 is oriented along a plane perpendicular to the application surface 102 and oriented obliquely at an angle relative to the third direction D3 which is preferably between 30° and 60°, even more preferably between 40° and 50°, for example equal to approximately 45°.

[0162] The service portion 412 further comprises a locking surface 414 facing the internal volume 402 when the slider 410 is in the first position. The locking surface 414 is oriented perpendicular to the coupling direction AL. The locking surface 414 is parallel to the stop surface 405. In particular, the locking surface 414 extends along the second direction D2 and the third direction D3.

[0163] The slider 410 further comprises an operating portion 416, shown in [Fig. 3], which is capable of being manually operated along the operating direction M1 to shift the slider 410 from the first position to the second position. The operating portion 416 projects from the main body 411 in the second direction D2 toward the application surface 102 until it is arranged outside the seat 400 through an opening 417 formed in the application surface 102.

[0164] The operating portion 416 is arranged substantially flush with the application surface 102 and includes a friction surface 418 parallel to the application surface 102 and configured to allow a user to move the slider 410 from the first position to the second position parallel to the friction surface 418 with his finger. Preferably, the friction surface 418 has a high roughness or surface asperities configured to increase friction with the user's finger.

[0165] The maneuvering portion 416 is positioned at the application surface 102 such that, when the device 1 is applied to the patient's body by the application surface 102, the maneuvering portion 416 is unreachable and cannot be reached.

[0166] An elastic element 419 is interposed between a first shoulder 420 formed in the seat 400 and a second shoulder 421 formed in the slider 410 so as to exert an elastic force against the slider 410. Preferably, the elastic element 419 is a spring.

[0167] When the slider 410 is in the first position, the elastic force of the elastic element 419 retains it in the first position, both before the coupling between the administration module 10 and the control module 20 and at the end of the coupling between the administration module 10 and the control module 20. In order to shift the slider from the first position to the second position, the user must exert on the maneuvering portion 416 a force along the maneuvering direction M1 such that it overcomes the elastic force of the elastic element 419. When the slider is in the second position, the elastic element 419 pushes it towards the first position.

[0168] In order to couple the control module 20 to the administration module 10, the two modules are moved towards each other until the coupling projections 230 are inserted into the coupling recesses 130 and the locking projection 300 into the seat 400 through the inlet 401. At this point, the control module 20 is caused to slide towards the administration module 10 along the coupling direction AL

[0169] As shown in Figures 8 to 10, the thrust portion 304 of the locking projection 300 engages in abutment with the thrust surface 413 of the slider 410, which is in the first position. Due to the oblique orientation of the thrust surface 413, the thrust portion 304, while moving along the coupling direction A1, shifts the slider 410 from the first position to the second position and slides on the thrust surface 413, overcoming the elastic thrust exerted on the slider 410 by the elastic member 419. In this way, the inlet 401 is accessible and the locking projection 300 can enter the internal volume 402. alternatively, the slider 410 can be moved from the first position to the second position by manually actuating the operating portion 416.

[0170] By continuing to move along the coupling direction A1, the thrust portion 304 becomes detached from the thrust surface 413 and the locking projection 300 reaches the internal volume 402. The slider 400 is thus free to return to the first position by means of the effect of the return action exerted by the elastic element 419, so that the service portion 412 of the slider 410 obstructs the inlet 401.

[0171] The locking projection 300, when housed in the internal volume 402, is encircled by: the stop surface 405, the guide surfaces 404 and the locking surfaces 414 and can no longer move in the coupling direction A1 in either direction. Furthermore, when the locking projection 300 is housed in the internal volume 402, the hooking portion 305 overlaps the hooking surface and prevents relative movements of the administration module 10 and the control module 20 perpendicular to the application surface 102.

[0172] The control module 20 is thus stably coupled to the administration module 10.

[0173] In this configuration, the closing projection 310 is positioned so as to close the inlet 401, as shown in [Fig.10].

Claims

Claims

1. Device (1) for subcutaneous administration of a medicament, comprising: - an administration module (10) configured to house a cartridge containing a medicament to be administered to a patient via a needle; - a control module (20) reversibly coupled to the administration module (10) and configured to house at least one control unit and a battery for supplying power to said control unit; wherein said administration module (10) comprises a first interface surface (115) facing the control module (20) and said control module (20) comprises a second interface surface (215) facing the first interface surface (115);wherein said first interface surface (115) comprises an inspection window (125) covered by the second interface surface (215) and configured to allow visual inspection of the cartridge when said control module (20) is decoupled from the administration module (10).;

2. Device (1) according to claim 1 wherein said administration module (10) comprises an application surface (102) configured to come into contact with the patient's body and wherein said administration module (10) is configured to house said cartridge between said application surface (102) and said inspection window (125).

3. Device (1) according to claim 1 or 2, wherein said inspection window (125) is parallel to said application surface (102).

4. Device (1) according to claim 2 or 3, wherein said application surface (102) comprises a light-permeable portion (107) configured to allow external light to reach said cartridge when said application surface (102) is not in contact with the patient's body.

5. Device (1) according to claim 4, wherein said light-permeable portion (107) and said inspection window (125) overlap each other.

6. Device (1) according to claim 4 or 5, wherein said light-permeable portion (107) is larger than said window inspection (125).

7. Device (1) according to any one of the preceding claims 4 to 6, wherein said application surface (102) comprises an opening (104) configured to allow insertion of the cartridge into the administration module (10) during assembly of the administration module (10), and wherein said light-permeable portion (107) comprises a transparent element (105) fixed at said opening (104) to close said opening (104).

8. Device (1) according to claim 7, wherein said application surface (102) comprises an adhesive layer (106) configured to attach said delivery module (10) to the patient's skin, a portion of said adhesive layer (106) being placed on said transparent element (105), said adhesive layer (106) being configured to allow external light to reach said cartridge when said application surface (102) is not in contact with the patient's body.

9. Device (1) according to claim 8, wherein said adhesive layer (106) is not transparent.